Mohammad Hossain
Overview
Explore the profile of Mohammad Hossain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
893
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gounder M, Johnson M, Heist R, Shapiro G, Postel-Vinay S, Wilson F, et al.
Nat Commun
. 2025 Jan;
16(1):423.
PMID: 39762248
Homozygous MTAP deletion occurs in ~15% of cancers, making them vulnerable to decreases in the concentration of S-adenosylmethionine (SAM). AG-270/S095033 is an oral, potent, reversible inhibitor of methionine adenosyltransferase 2 ...
2.
Nishimura F, Sampaio B, Komoto T, da Silva W, da Costa M, Haddad G, et al.
Int J Mol Sci
. 2024 May;
25(9).
PMID: 38732206
Breast cancer stands out as one of the most prevalent malignancies worldwide, necessitating a nuanced understanding of its molecular underpinnings for effective treatment. Hormone receptors in breast cancer cells substantially...
3.
DiNardo C, Roboz G, Watts J, Madanat Y, Prince G, Baratam P, et al.
Blood Adv
. 2024 Apr;
8(15):4209-4220.
PMID: 38640348
Ivosidenib is a first-in-class mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor with efficacy and tolerability in patients with advanced mIDH1 hematologic malignancies, leading to approval in frontline and relapsed/refractory (R/R) mIDH1...
4.
Nishimura F, Sampaio B, do Couto G, da Silva A, da Silva W, Peronni K, et al.
Molecules
. 2024 Mar;
29(6).
PMID: 38543002
Breast cancer represents a critical global health issue, accounting for a substantial portion of cancer-related deaths worldwide. Metastasis, the spread of cancer cells to distant organs, is the primary cause...
5.
Hilliard J, Jakielaszek C, Mannino F, Hossain M, Qian L, Fishman C, et al.
Antimicrob Agents Chemother
. 2024 Feb;
68(3):e0149723.
PMID: 38358266
is a Gram-positive Centers for Disease Control and Prevention category "A" biothreat pathogen. Without early treatment, inhalation of anthrax spores with progression to inhalational anthrax disease is associated with high...
6.
Fan B, Abou-Alfa G, Zhu A, Pandya S, Jia H, Yin F, et al.
Cancer Chemother Pharmacol
. 2024 Jan;
93(5):471-479.
PMID: 38278871
Purpose: Report pharmacokinetic (PK)/pharmacodynamic (PD) findings from the phase III ClarIDHy study and any association between PK/PD parameters and treatment outcomes in this population. Methods: Patients with mutant isocitrate dehydrogenase...
7.
Das S, Roayapalley P, Sakagami H, Umemura N, Gorecki D, Hossain M, et al.
Medicines (Basel)
. 2024 Jan;
11(1).
PMID: 38248717
The objective of this study is to find novel antineoplastic agents that display greater toxicity to malignant cells than to neoplasms. In addition, the mechanisms of action of representative compounds...
8.
Fournier J, Russell C, Hossain M
Cureus
. 2024 Jan;
15(11):e49711.
PMID: 38161810
Endocrine mucin-producing sweat gland carcinoma (EMPSGC) is a rare, low-grade neuroendocrine neoplasm previously believed to be indolent in nature. There have only previously been six reported cases of metastases and...
9.
Yesmin M, Chowdhury M, Bornee F, Kader M, Mondal M, Hossain M, et al.
Front Public Health
. 2023 Nov;
11:1270853.
PMID: 38026377
Objective: Early childhood functional difficulty poses a substantial worldwide public health challenge, leading to adverse effects on children's quality of life and overall productivity. Moreover, it represents a significant social...
10.
Patel S, Alshami A, Douedi S, Udongwo N, Hossain M, Tarina D, et al.
Healthcare (Basel)
. 2023 Nov;
11(21).
PMID: 37957968
With the recent change to value-based care, institutions have struggled with the appropriate management of patients under observation. Observation status can have a huge impact on hospital and patient expenses....